Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
400.41
+0.25 (+0.06%)
Streaming Delayed Price
Updated: 12:08 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
Down 88%, Could Editas Medicine Be a Good Investment Now?
January 15, 2024
The past few years have been difficult ones, but shares of the gene editor are far more attractive now that a CRISPR medicine has passed regulatory hurdles.
Via
The Motley Fool
My 3 Highest-Conviction Growth Stocks to Buy in 2024
January 14, 2024
Simply put, these stocks inspire confidence.
Via
The Motley Fool
3 Growth Stocks to Buy That Could Be Massive Long-Term Winners
January 14, 2024
These stocks appear to have what it takes to keep up their winning ways.
Via
The Motley Fool
3 Unstoppable Stocks to Buy in 2024
January 13, 2024
These stocks appear to be on a clear path to continued growth.
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
January 13, 2024
These companies could stand out thanks to game-changing technology.
Via
The Motley Fool
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
January 11, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 16 Analysts
January 09, 2024
Via
Benzinga
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings
January 09, 2024
Via
Benzinga
Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
January 12, 2024
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said Uber Technologies, Inc. (NYSE: UBER) shares hit an all-time high on Thursda
Via
Benzinga
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
As the promise of gene editing moves closer to being a reality, these gene editing stocks have the opportunity for long-term gains.
Via
InvestorPlace
Should Quality-Oriented Investors Explore VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX)?
January 11, 2024
Reasonable growth and debt and a high ROIC for VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX).
Via
Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
January 10, 2024
Via
Benzinga
2 Red Flags for Bluebird Bio Stock
January 10, 2024
The biotech's struggles may continue.
Via
The Motley Fool
$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today
January 08, 2024
Via
Benzinga
Is Vertex Pharmaceuticals Stock a Buy Now?
January 06, 2024
The biotech's prospects keep improving.
Via
The Motley Fool
These 3 Stocks Have Beaten the S&P Average Return for Years and Are Likely to Continue That Trend
January 10, 2024
These winners seem likely to keep up their winning ways.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia
January 09, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
2 low-priced gene therapy stocks to speculate on
January 08, 2024
Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic diffe
Via
MarketBeat
Exposures
Product Safety
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
The rebound by biopharma stocks in 2023 and the pickup in M&A news flow makes the 2024 JPMorgan Healthcare conference even more interesting.
Via
Benzinga
The Ultimate Growth Stock to Buy With $1,000 Right Now
January 08, 2024
The stock, trading for about $60, has plenty of room to run.
Via
The Motley Fool
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
January 07, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
5 Top Stocks to Buy in January
January 07, 2024
Start the year off right by investing in these quality businesses.
Via
The Motley Fool
Investing Trends to Follow in 2024
January 06, 2024
We've also got Motley Fool co-founder Tom Gardner sharing an investing lesson from last year and a stock for this one.
Via
The Motley Fool
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via
Investor's Business Daily
2 Biotech Stocks With Huge Catalysts in 2024
January 05, 2024
Important clinical-trial readouts on the way could send these stocks soaring in early 2024.
Via
The Motley Fool
Gen Z’s Top Picks for 2024: 7 Trending Stocks Among Young Investors
January 04, 2024
Gen Z stocks include companies the generation prefers to invest in while capturing the emerging economic force they represent.
Via
InvestorPlace
Will the Biotech sector sustain its momentum in 2024?
January 04, 2024
The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%.
Via
MarketBeat
Topics
ETFs
The Best Stocks to Invest $1,000 in Right Now
January 04, 2024
It's not too late to get in on these market beaters.
Via
The Motley Fool
Here's Why 2024 Could Be a Big Year for CRISPR Therapeutics
January 04, 2024
CRISPR Therapeutics' shares climbed considerably last year -- but more gains could be just ahead.
Via
The Motley Fool
3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition
January 03, 2024
Healthcare stocks tend to be more mature and reliable, but a handful of innovators offer massive long-term upside.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
46
47
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.